Can-Fite Reports 2023 Financial Results and Clinical Update
Go back to Can-Fite Reports 2023 Financial Results and Clinical Update| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 2.25 +0.03 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.22 | 52 Week High | $3.89 | |||
| Open | $2.22 | 52 Week Low | $1.85 | |||
| Day High | $2.25 | P/E | N/A | |||
| Day Low | $2.20 | EPS | $0.00 | |||
| Volume | 17,233 | |||||
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 2.25 +0.03 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.22 | 52 Week High | $3.89 | |||
| Open | $2.22 | 52 Week Low | $1.85 | |||
| Day High | $2.25 | P/E | N/A | |||
| Day Low | $2.20 | EPS | $0.00 | |||
| Volume | 17,233 | |||||

